MIR22 Gene

HGNC Family Non-coding RNAs
Name microRNA 22
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐22 is a multifunctional regulator whose effects depend on cellular context. In breast cancer models, for example, miR‐22 promotes epithelial–mesenchymal transition, enhances invasiveness and expands the cancer stem cell compartment via targeting TET‐family dioxygenases and thereby silencing antimetastatic miR‐200."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " By contrast, in hematopoietic malignancies its upregulation fosters aberrant stem cell self‐renewal and contributes to malignant transformation through repression of TET2"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", whereas in other settings miR‐22 triggers cellular senescence through downregulation of key cell cycle and survival regulators including CDK6, SIRT1 and Sp1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn hormone‐dependent cancers, miR‐22 directly represses estrogen receptor α by targeting its extended 3′ untranslated region (UTR)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and further diminishes oncogenic signals by reducing CD147 expression through both direct targeting of its 3′UTR and indirect modulation via Sp1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Moreover, miR‐22 regulates mesenchymal lineage choices by attenuating adipogenic differentiation while promoting osteogenesis through suppression of HDAC6"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", and it also participates in the control of vascular cell phenotypes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMiR‐22 further modulates critical oncogenic signaling pathways and stress responses. In colon cancer, its overexpression reduces hypoxia‐induced HIF‐1α and VEGF production, thereby exerting an anti‐angiogenic effect."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " In response to genotoxic stress, miR‐22 is induced as a p53 target and functions to repress p21, favoring apoptosis over cell cycle arrest."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Notably, in p53‐mutant colon cancer cells, enforced miR‐22 expression can enhance chemosensitivity through upregulation of PTEN and subsequent attenuation of the AKT pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA broad spectrum of miR‐22 targets further underscores its role in curbing oncogenic signals. MiR‐22 downregulates MYCBP, an essential coactivator of c-Myc, thereby dampening proliferative cascades"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", and in acute myeloid leukemia its restoration inhibits leukaemic cell viability."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " In diverse tumor types—including gastric, breast, bladder and melanoma—miR‐22 suppresses epithelial–mesenchymal transition and invasion by targeting key regulators such as MMP14, Snail and MAPK1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "20"}]}, {"type": "t", "text": " Moreover, in Ewing sarcoma, reduced miR‐22 levels permit overexpression of the histone demethylase KDM3A, while in osteosarcoma it targets HMGB1 to block autophagy and mitigate chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMiR‐22 is also embedded within a complex regulatory network that integrates diverse extracellular and intracellular signals. Long noncoding RNAs and circular RNAs—such as DGCR5 and MALAT1—can sequester miR‐22, thereby modulating its availability and impacting pathways including NF‐κB signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "26"}]}, {"type": "t", "text": " In addition, regulatory inputs from agents like diallyl disulfide lead to miR‐22 upregulation and cooperate with other miRNAs (e.g. miR‐200b) to target oncogenic factors, including Wnt‐1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": " The modulation of endothelial function by MALAT1 via miR‐22, which affects CXCR2 expression and the AKT pathway, further illustrates its role in vascular homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": " Circulating miR‐22 levels have been proposed as non‐invasive biomarkers in settings such as prostate cancer, premature ovarian failure and endometriosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "32"}]}, {"type": "t", "text": " Moreover, miR‐22 can temper NF‐κB activity by targeting coactivators"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": ", and it controls glucocerebrosidase expression via interactions with its pseudogene GBAP1, a mechanism relevant to Parkinson’s disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": " Finally, its transcriptional induction by bile acid–activated FXR, which leads to cyclin A2 suppression, and its upregulation by TPA to modulate the Myc–Max axis, underscore additional layers of regulation that link miR‐22 to differentiation and growth arrest."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Su Jung Song, Laura Poliseno, Min Sup Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2013.06.026"}], "href": "https://doi.org/10.1016/j.cell.2013.06.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23830207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23830207"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Su Jung Song, Keisuke Ito, Ugo Ala, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Stem Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.stem.2013.06.003"}], "href": "https://doi.org/10.1016/j.stem.2013.06.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23827711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23827711"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dan Xu, Fumitaka Takeshita, Yumiko Hino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 represses cancer progression by inducing cellular senescence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201010100"}], "href": "https://doi.org/10.1083/jcb.201010100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21502362"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21502362"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "J Zhang, Y Yang, T Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6605895"}], "href": "https://doi.org/10.1038/sj.bjc.6605895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20842113"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20842113"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Deo Prakash Pandey, Didier Picard "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01875-08"}], "href": "https://doi.org/10.1128/MCB.01875-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19414598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19414598"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jianhua Xiong, Dianke Yu, Na Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2010.07594.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2010.07594.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20180843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20180843"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ling-Min Kong, Cheng-Gong Liao, Yang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-3555"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-3555"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24906624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24906624"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shan Huang, Shihua Wang, Chunjing Bian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells Dev (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/scd.2012.0014"}], "href": "https://doi.org/10.1089/scd.2012.0014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22375943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22375943"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Feng Yang, Qishan Chen, Shiping He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.117.027799"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.117.027799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29246895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29246895"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhi Zeng, Luoxing Xia, Shunyang Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.120.049715"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.120.049715"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33207953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33207953"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Munekazu Yamakuchi, Shusuke Yagi, Takashi Ito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-22 regulates hypoxia signaling in colon cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0020291"}], "href": "https://doi.org/10.1371/journal.pone.0020291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21629773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21629773"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Naoto Tsuchiya, Masashi Izumiya, Hiroko Ogata-Kawata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-2475"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-2475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21565979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21565979"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jian Li, Yangde Zhang, Jingfeng Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-011-0872-8"}], "href": "https://doi.org/10.1007/s11010-011-0872-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21594648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21594648"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "J Xiong, Q Du, Z Liang "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.241"}], "href": "https://doi.org/10.1038/onc.2010.241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20562918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20562918"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xi Jiang, Chao Hu, Stephen Arnovitz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms11452"}], "href": "https://doi.org/10.1038/ncomms11452"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27116251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27116251"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Q-F Zuo, L-Y Cao, T Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2015.297"}], "href": "https://doi.org/10.1038/cddis.2015.297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26610210"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26610210"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "J B Patel, H N Appaiah, R M Burnett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.510"}], "href": "https://doi.org/10.1038/onc.2010.510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21057539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21057539"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Wenkang Luan, Lubo Li, Yan Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11564"}], "href": "https://doi.org/10.18632/oncotarget.11564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27564100"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27564100"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Mei-Mei Guo, Li-Hua Hu, Yong-Qiang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-013-0542-7"}], "href": "https://doi.org/10.1007/s12032-013-0542-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23529765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23529765"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mingjie Xu, Jiangfeng Li, Xiao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-017-0206-1"}], "href": "https://doi.org/10.1038/s41419-017-0206-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29434190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29434190"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "J K Parrish, M Sechler, R A Winn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.541"}], "href": "https://doi.org/10.1038/onc.2013.541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24362521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24362521"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fan Yang, Ying Hu, Hui-Xin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.620369"}], "href": "https://doi.org/10.1074/jbc.M114.620369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25596928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25596928"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Shibing Guo, Rui Bai, Wanlin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-1965-2"}], "href": "https://doi.org/10.1007/s13277-014-1965-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24752578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24752578"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Hui-Xing Dong, Ren Wang, Xiao-Yan Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.26215"}], "href": "https://doi.org/10.1002/jcp.26215"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29030962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29030962"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "S Li, X Liang, L Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2017.381"}], "href": "https://doi.org/10.1038/onc.2017.381"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29059152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29059152"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shuang-Zheng Jia, Yunpeng Yang, Jinghe Lang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/des413"}], "href": "https://doi.org/10.1093/humrep/des413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23203215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23203215"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Hailin Tang, Yanan Kong, Jiaoli Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2013.06.027"}], "href": "https://doi.org/10.1016/j.canlet.2013.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23851184"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23851184"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Yong Tang, Xian Jin, Yin Xiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.08.046"}], "href": "https://doi.org/10.1016/j.febslet.2015.08.046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26364720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26364720"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yaxian Song, Lixia Yang, Ruiwei Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.12.139"}], "href": "https://doi.org/10.1016/j.bbrc.2018.12.139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30591217"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30591217"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Lorenza Pasqualini, Huajie Bu, Martin Puhr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2014-1358"}], "href": "https://doi.org/10.1210/me.2014-1358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26052614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26052614"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yujie Dang, Shidou Zhao, Yingying Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-22-3p is down-regulated in the plasma of Han Chinese patients with premature ovarian failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fertil Steril (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.fertnstert.2014.12.106"}], "href": "https://doi.org/10.1016/j.fertnstert.2014.12.106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25585503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25585503"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Lu Zhang, Huihui Li, Ming Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/2456340"}], "href": "https://doi.org/10.1155/2020/2456340"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32076458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32076458"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Akemi Takata, Motoyuki Otsuka, Kentaro Kojima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2011.07.048"}], "href": "https://doi.org/10.1016/j.bbrc.2011.07.048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21798241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21798241"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Letizia Straniero, Valeria Rimoldi, Maura Samarani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-12973-5"}], "href": "https://doi.org/10.1038/s41598-017-12973-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28983119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28983119"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Li Gan, Lin Lv, Shengtao Liao "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2019.4773"}], "href": "https://doi.org/10.3892/ijo.2019.4773"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31081061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31081061"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Yi Ting, Daniel J Medina, Roger K Strair, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.03.030"}], "href": "https://doi.org/10.1016/j.bbrc.2010.03.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20214878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20214878"}]}]}]}
Synonyms MIR-22, MIRN22, HSA-MIR-22
NCBI Gene ID 407004
API
Download Associations
Predicted Functions View MIR22's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR22's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR22's ARCHS4 Predicted Functions.

Functional Associations

MIR22 has 2,107 functional associations with biological entities spanning 5 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 21 datasets.

Click the + buttons to view associations for MIR22 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR22 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR22 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR22 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with MIR22 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR22 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR22 gene/protein from the curated CTD Gene-Disease Associations dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with MIR22 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR22 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR22 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR22 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR22 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR22 from the GeneSigDB Published Gene Signatures dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR22 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR22 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR22 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MIR22 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR22 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR22 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MIR22 gene mutations from the MPO Gene-Phenotype Associations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR22 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with MIR22 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.